FI112080B - 2-(2-amino-1,6-dihydro-6-oksopurin-9-yyli)metoksi-3-hydroksi-1-propanyyli-L-valinaatti - Google Patents
2-(2-amino-1,6-dihydro-6-oksopurin-9-yyli)metoksi-3-hydroksi-1-propanyyli-L-valinaatti Download PDFInfo
- Publication number
- FI112080B FI112080B FI953592A FI953592A FI112080B FI 112080 B FI112080 B FI 112080B FI 953592 A FI953592 A FI 953592A FI 953592 A FI953592 A FI 953592A FI 112080 B FI112080 B FI 112080B
- Authority
- FI
- Finland
- Prior art keywords
- amino
- methoxy
- dihydro
- compound
- oxopurin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28189394A | 1994-07-28 | 1994-07-28 | |
US28189394 | 1994-07-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI953592A0 FI953592A0 (fi) | 1995-07-27 |
FI953592A FI953592A (fi) | 1996-01-29 |
FI112080B true FI112080B (fi) | 2003-10-31 |
Family
ID=23079211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI953592A FI112080B (fi) | 1994-07-28 | 1995-07-27 | 2-(2-amino-1,6-dihydro-6-oksopurin-9-yyli)metoksi-3-hydroksi-1-propanyyli-L-valinaatti |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP0694547B1 (ar) |
JP (1) | JP3090305B2 (ar) |
KR (1) | KR100358626B1 (ar) |
CN (1) | CN1045089C (ar) |
AT (1) | ATE179173T1 (ar) |
AU (1) | AU697107B2 (ar) |
BR (1) | BR9503468A (ar) |
CA (1) | CA2154721C (ar) |
CO (1) | CO4410181A1 (ar) |
CY (2) | CY2180B1 (ar) |
CZ (1) | CZ290511B6 (ar) |
DE (3) | DE69509173T2 (ar) |
DK (1) | DK0694547T3 (ar) |
ES (1) | ES2083348T3 (ar) |
FI (1) | FI112080B (ar) |
GR (2) | GR960300021T1 (ar) |
HK (1) | HK1012339A1 (ar) |
HU (1) | HU216867B (ar) |
IL (1) | IL114735A (ar) |
LU (1) | LU91136I2 (ar) |
MA (1) | MA23631A1 (ar) |
MY (1) | MY114393A (ar) |
NL (1) | NL300071I2 (ar) |
NO (2) | NO312899B1 (ar) |
NZ (1) | NZ272652A (ar) |
PE (1) | PE32296A1 (ar) |
PL (1) | PL180609B1 (ar) |
RU (1) | RU2133749C1 (ar) |
SA (1) | SA95160158B1 (ar) |
TR (1) | TR199500895A2 (ar) |
TW (1) | TW434242B (ar) |
UY (1) | UY24006A1 (ar) |
ZA (1) | ZA956228B (ar) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
AU1592897A (en) * | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
AU1543797A (en) * | 1996-01-26 | 1997-08-20 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US5700936A (en) * | 1996-01-26 | 1997-12-23 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate |
US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US5869493A (en) * | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
US6184376B1 (en) | 1997-02-10 | 2001-02-06 | Mediver Ab | Synthesis of acyclic nucleoside derivatives |
DE69809205T2 (de) * | 1997-02-10 | 2003-05-28 | Medivir Ab, Huddinge | Verfahren zur herstellung von azyklischen nukleosiden |
KR100529272B1 (ko) * | 1997-08-15 | 2005-11-17 | 메디비르 아베 | 레트로바이러스 역전사효소 및 b형 간염바이러스(hbv)의 dna 중합효소의 억제제를 포함한항바이러스제와 같은 뉴클레오시드 유사체 |
WO1999032490A1 (en) * | 1997-12-19 | 1999-07-01 | Bristol-Myers Squibb Company | Prodrugs of lobucavir and methods of use |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
KR20030015655A (ko) * | 2001-08-17 | 2003-02-25 | 한미약품공업 주식회사 | 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물 |
DE60328675D1 (de) * | 2002-04-23 | 2009-09-17 | Aventis Pharma Inc | 3-(substitutierte amino)-1h-indole-2-carbonsäureester und 3-(substitutierte amino)-benzoäbüthiophen-2-carbonsäureester verbindungen als inhibitoren der interleukin-4 genexpression |
ES2534713T3 (es) | 2002-10-16 | 2015-04-27 | Takeda Pharmaceutical Company Limited | Preparaciones sólidas estables |
EA015145B1 (ru) | 2003-01-14 | 2011-06-30 | Джилид Сайэнс, Инк. | Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции |
CA2537132A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Amorphous valganciclovir hydrochloride |
AU2005264864B2 (en) | 2004-06-16 | 2011-08-11 | Takeda Pharmaceutical Company Limited | Multiple PPI dosage form |
PL1773878T3 (pl) * | 2004-07-19 | 2015-07-31 | Biocon Ltd | Koniugaty insulina-oligomer, ich formulacje i zastosowania |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
ZA200702234B (en) * | 2006-03-21 | 2008-07-30 | Cipla Ltd | Preparation of ester of purine derivatives |
RU2010119041A (ru) | 2007-10-12 | 2011-11-20 | Такеда Фармасьютикалз Норт Америка, Инк. (Us) | Способы лечения нарушений желудочно-кишечного тракта, независимого от потребления пищи |
WO2012163373A1 (en) | 2011-05-31 | 2012-12-06 | Pharmathen S.A. | Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir |
KR102312533B1 (ko) | 2021-02-24 | 2021-10-15 | 주식회사 이웅 | 자동 스패너 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8202626A (nl) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | Derivaten van 9-(2-hydroxyethoxymethyl)guanine. |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
NO172183C (no) * | 1984-12-12 | 1993-06-16 | Syntex Inc | Fremgangsmaate for fremstilling av derivater av 9-(1,3-dikydroksy-2-propoksymetyl)-guanin |
AP160A (en) * | 1987-08-15 | 1991-11-18 | The Wellcome Foundation Ltd | Therapeutic acyclic nucleosides. |
US5043339A (en) * | 1988-12-19 | 1991-08-27 | Burroughs Wellcome Co. | Antiviral compounds |
-
1995
- 1995-07-10 PE PE1995273436A patent/PE32296A1/es not_active IP Right Cessation
- 1995-07-19 EP EP95111319A patent/EP0694547B1/en not_active Expired - Lifetime
- 1995-07-19 DK DK95111319T patent/DK0694547T3/da active
- 1995-07-19 AT AT95111319T patent/ATE179173T1/de active
- 1995-07-19 ES ES95111319T patent/ES2083348T3/es not_active Expired - Lifetime
- 1995-07-19 DE DE69509173T patent/DE69509173T2/de not_active Expired - Lifetime
- 1995-07-19 DE DE2002199032 patent/DE10299032I2/de active Active
- 1995-07-19 DE DE0694547T patent/DE694547T1/de active Pending
- 1995-07-21 TR TR95/00895A patent/TR199500895A2/xx unknown
- 1995-07-26 AU AU27195/95A patent/AU697107B2/en not_active Expired
- 1995-07-26 MA MA23971A patent/MA23631A1/fr unknown
- 1995-07-26 IL IL114735A patent/IL114735A/en not_active IP Right Cessation
- 1995-07-26 ZA ZA956228A patent/ZA956228B/xx unknown
- 1995-07-26 HU HU9502238A patent/HU216867B/hu unknown
- 1995-07-26 NZ NZ272652A patent/NZ272652A/en not_active IP Right Cessation
- 1995-07-26 CA CA002154721A patent/CA2154721C/en not_active Expired - Lifetime
- 1995-07-27 BR BR9503468A patent/BR9503468A/pt active Search and Examination
- 1995-07-27 JP JP07190953A patent/JP3090305B2/ja not_active Expired - Lifetime
- 1995-07-27 MY MYPI95002156A patent/MY114393A/en unknown
- 1995-07-27 PL PL95309812A patent/PL180609B1/pl unknown
- 1995-07-27 UY UY24006A patent/UY24006A1/es not_active IP Right Cessation
- 1995-07-27 CN CN95109671A patent/CN1045089C/zh not_active Expired - Lifetime
- 1995-07-27 CZ CZ19951939A patent/CZ290511B6/cs not_active IP Right Cessation
- 1995-07-27 RU RU95113148A patent/RU2133749C1/ru active
- 1995-07-27 TW TW084107779A patent/TW434242B/zh not_active IP Right Cessation
- 1995-07-27 CO CO95033418A patent/CO4410181A1/es unknown
- 1995-07-27 FI FI953592A patent/FI112080B/fi active Protection Beyond IP Right Term
- 1995-07-27 KR KR1019950022600A patent/KR100358626B1/ko not_active IP Right Cessation
- 1995-07-27 NO NO19952977A patent/NO312899B1/no not_active IP Right Cessation
- 1995-08-14 SA SA95160158A patent/SA95160158B1/ar unknown
-
1996
- 1996-04-30 GR GR960300021T patent/GR960300021T1/el unknown
-
1998
- 1998-12-15 HK HK98113443A patent/HK1012339A1/xx not_active IP Right Cessation
-
1999
- 1999-07-02 GR GR990401760T patent/GR3030678T3/el unknown
-
2000
- 2000-08-10 CY CY0000039A patent/CY2180B1/xx unknown
-
2001
- 2001-11-23 NL NL300071C patent/NL300071I2/nl unknown
-
2003
- 2003-01-10 NO NO2003001C patent/NO2003001I2/no unknown
- 2003-05-21 LU LU91136C patent/LU91136I2/fr unknown
-
2004
- 2004-10-20 CY CY200400003C patent/CY2004003I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI112080B (fi) | 2-(2-amino-1,6-dihydro-6-oksopurin-9-yyli)metoksi-3-hydroksi-1-propanyyli-L-valinaatti | |
US6083953A (en) | 2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivative | |
JP7367908B2 (ja) | 標的タンパク質分解化合物、その抗腫瘍応用、その中間体および中間体の応用 | |
FI89713B (fi) | Foerfarande foer framstaellning av terapeutiskt aktivt 2-(2-amino-1,6-dihydro-6-oxo-9h(purin-9-yl)metoxi)etyl-l-valinat eller l-isoleucinat eller deras salt | |
US9315523B2 (en) | Cyclic dinucleosides | |
US5543414A (en) | Achiral amino acid acyl esters of ganciclovir and its derivatives | |
EP3919488A1 (en) | Immunomodulator | |
EP1019403A1 (en) | Process for preparing purine derivatives | |
EP2865669B1 (en) | Novel rebamipide prodrug, method for producing same, and usage thereof | |
KR19990076616A (ko) | 2,7-치환된 옥타하이드로-피롤로[1,2-에이]피라진 유도체 | |
JP2001503767A (ja) | ヌクレオシド | |
ES2180923T5 (es) | Proceso para la preparacion de derivados de purina. | |
ES2641190T3 (es) | Procedimiento de síntesis de IB-MECA | |
EP1891071B1 (en) | Cyclopropanecarboxylate esters of acyclovir | |
TW202339766A (zh) | 非環狀硫醇前藥 | |
KR100290533B1 (ko) | 항바이러스 활성을 가지는 2-아미노퓨린 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Supplementary protection certificate application filed |
Spc suppl protection certif: L20040001 |
|
SPCE | Application for extension of a supplementary protection certificate [pediatric extension] |
Spc suppl protection certif: L20040001 |
|
MA | Patent expired | ||
SPCP | Extension of a supplementary protection certificate [pediatric extension] |
Spc suppl protection certif: 241 Extension date: 20170320 |